{"DataElement":{"publicId":"2672550","version":"1","preferredName":"Preparative Regimen Cyclophosphamide Planned Administered Medication Dose Value","preferredDefinition":"The numeric value related to the dose of the planned cyclophosphamide preparative regimen.","longName":"2671487v1.0:2614721v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2671487","version":"1","preferredName":"Preparative Regimen Cyclophosphamide Planned Administered","preferredDefinition":"information related to the planned administration of a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities given to bone marrow transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur.","longName":"2671485v1.0:2207843v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2671485","version":"1","preferredName":"Preparative Regimen Cyclophosphamide","preferredDefinition":"The chemotherapy and/or radiation given to bone marrow transplant patients prior to transplant to kill\r\ndiseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not\r\noccur.:A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04)","longName":"C61155:C405","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cyclophosphamide","conceptCode":"C405","definition":"A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"379420B2-EF49-509D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-13","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-13","modifiedBy":"ONEDATA","dateModified":"2007-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207843","version":"1","preferredName":"Planned Administered","preferredDefinition":"Planned; devised, contrived, or formed in design.:Given.","longName":"C25619:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3254-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"379420B2-EF57-509D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-09","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Changed Property from Adminstration to Administered as part of cleanup. SW 01/21/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2614721","version":"1","preferredName":"Medication Dose Value","preferredDefinition":"Numeric value to capture the amount of medication delivered in a dose.","longName":"MED_DOSE_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2614720","version":"1","preferredName":"Medication Dose Value","preferredDefinition":"biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.:The amount of medicine taken, or radiation given, at one time.:A numerical quantity measured or assigned or computed.","longName":"C459:C25488:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C328754-6732-235C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-21","modifiedBy":"ONEDATA","dateModified":"2007-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C328754-6743-235C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-21","modifiedBy":"REEVESD","dateModified":"2007-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964924","version":"1","longName":"2400r1: Pre-TED","context":"NHLBI"}]}],"AlternateNames":[{"name":"2671487v1.0:2614721v1.0","type":"USED_BY","context":"CTEP"}],"ReferenceDocuments":[{"name":"What was the total prescribed","type":"Preferred Question Text","description":"What was the total prescribed cumulative dose of cyclophosphamide for the preparative regimen (per the protocol)?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"37AC035E-AD16-55C8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-14","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-14","modifiedBy":"KUMMEROA","dateModified":"2021-04-29","changeDescription":"Cleanup; 6/23/08mn-chgd 'cyclophophamide' in qstn txt.\\\\\\Changed names and defs due to changes in DEC. SW 01/21/2010 Alt name \"pre_ted_prep_cytoxan_dose\" removed due to being used on CDE 3040323. AK 9/12/16 System generated def displayed as alt def. 2021-4-29 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}